CHRISTOPHER PELTON: Open Payments
NPI 1184016529 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 81 payments from 16 companies in 2025. Trend: 2023 $765 · 2024 $1,427 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $345 |
| Lilly USA, LLC | 11 | $187 |
| Novo Nordisk Inc | 9 | $159 |
| PFIZER INC. | 14 | $151 |
| Abbott Laboratories | 5 | $103 |
| Antares Pharma, Inc. | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 6 | $82 |
| ABBVIE INC. | 3 | $59 |
| Amgen Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $36 |
Products named: FARXIGA, MOUNJARO, AIRSUPRA, NURTEC ODT, FREESTYLE LIBRE 3, XYOSTED, Ozempic, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
